Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus (IPG257)
Fast, easy summary view of NICE guidance on 'diabetes'
NICE has now issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus.
This document together with the guidance published IPG274 on autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy (http://www.nice.org.uk/ipg274guidance) replaces previous guidance IPG013 on pancreatic islet cell transplantation.
Type 1 diabetes mellitus is a condition that occurs when the body does not produce enough insulin (a substance that helps control sugar balance in the body). It is usually treatable with insulin injections, but people with type 1 diabetes mellitus have an increased risk of other health problems, such heart disease. Allogeneic pancreatic islet cell transplantation involves the removal of cells called islet cells, which are responsible for the production of insulin, from human donors. These cells are inserted into the patient's liver to restart insulin production within the body. However, patients who have this procedure will need to take medications to help their bodies' immune system to accept the cells.
J54.4 Transplantation of islet of Langerhans
Y27.2 Allograft to organ NOC
Y53. - Approach to organ under image control
Note:†Codes within category Y53.- are used as secondary codes to classify interventions that are percutaneous and require some form of image control: if the method of image control is unspecified, Y53.9 Unspecified approach to organ under image control is assigned.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. ††The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided.† www.connectingforhealth.co.uk/clinicalcoding
- IPG257 Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus: guidance (web format)
- Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus (interventional procedures consultation)
- Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus (interventional procedures overview)
- IPG257 Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus: guidance
- IPG257 Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus: understanding NICE guidance (MS Word format)
- IPG257 Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus: consultation comments
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: diabetes
This page was last updated: 06 April 2011
- Web format
- Full Guidance (PDF)
- IPG257 Trawsblannu celloedd ynysoedd pancreatig a roddir i gleifion sydd ‚ diabetes math 1: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.